Progress of pancreatic surgical treatment in 2023
10.3760/cma.j.cn113855-20231108-00316
- VernacularTitle:2023年度胰腺外科治疗进展及焦点展望
- Author:
Ruobing WANG
1
;
Yueze LIU
;
Taiping ZHANG
Author Information
1. 中国医学科学院北京协和医学院 北京协和医院基本外科，北京 100730
- Keywords:
Pancreatitis;
Pancreatic neoplasms;
Surgical treatment;
Neoadjuvant therapy;
Progress
- From:
Chinese Journal of General Surgery
2024;39(1):14-18
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic surgery is one of the most challenging specialties in general surgery. Due to the variety of pancreatic diseases, the difficulty of surgery, and the differences in diagnosis and treatment among different diseases, treatment strategies for these diseases remain controversial. From the aspects of surgical treatment such as pancreatitis, pancreatic cystic neoplasms, pancreatic neuroendocrine neoplasms, and pancreatic cancer, as well as neoadjuvant therapy, adjuvant therapy, immunotherapy, and targeted therapy. We review and summarize the frontier progress of clinical and translational research in pancreatic surgery in 2023, in order to further standardize the diagnosis and treatment of pancreatic surgery.
